purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Clinical Trials Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pre-Clinical Phase
1.2.3 Phase I
1.2.4 Phase II
1.2.5 Phase III
1.3 Market by Application
1.3.1 Global Pediatric Clinical Trials Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Neuropsychiatric Conditions
1.3.3 Infectious Diseases
1.3.4 Respiratory Diseases
1.3.5 Cardiovascular Diseases
1.3.6 Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Clinical Trials Market Perspective (2017-2028)
2.2 Pediatric Clinical Trials Growth Trends by Region
2.2.1 Pediatric Clinical Trials Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pediatric Clinical Trials Historic Market Size by Region (2017-2022)
2.2.3 Pediatric Clinical Trials Forecasted Market Size by Region (2023-2028)
2.3 Pediatric Clinical Trials Market Dynamics
2.3.1 Pediatric Clinical Trials Industry Trends
2.3.2 Pediatric Clinical Trials Market Drivers
2.3.3 Pediatric Clinical Trials Market Challenges
2.3.4 Pediatric Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Clinical Trials Players by Revenue
3.1.1 Global Top Pediatric Clinical Trials Players by Revenue (2017-2022)
3.1.2 Global Pediatric Clinical Trials Revenue Market Share by Players (2017-2022)
3.2 Global Pediatric Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Clinical Trials Revenue
3.4 Global Pediatric Clinical Trials Market Concentration Ratio
3.4.1 Global Pediatric Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Clinical Trials Revenue in 2021
3.5 Pediatric Clinical Trials Key Players Head office and Area Served
3.6 Key Players Pediatric Clinical Trials Product Solution and Service
3.7 Date of Enter into Pediatric Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Clinical Trials Breakdown Data by Type
4.1 Global Pediatric Clinical Trials Historic Market Size by Type (2017-2022)
4.2 Global Pediatric Clinical Trials Forecasted Market Size by Type (2023-2028)
5 Pediatric Clinical Trials Breakdown Data by Application
5.1 Global Pediatric Clinical Trials Historic Market Size by Application (2017-2022)
5.2 Global Pediatric Clinical Trials Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pediatric Clinical Trials Market Size (2017-2028)
6.2 North America Pediatric Clinical Trials Market Size by Type
6.2.1 North America Pediatric Clinical Trials Market Size by Type (2017-2022)
6.2.2 North America Pediatric Clinical Trials Market Size by Type (2023-2028)
6.2.3 North America Pediatric Clinical Trials Market Share by Type (2017-2028)
6.3 North America Pediatric Clinical Trials Market Size by Application
6.3.1 North America Pediatric Clinical Trials Market Size by Application (2017-2022)
6.3.2 North America Pediatric Clinical Trials Market Size by Application (2023-2028)
6.3.3 North America Pediatric Clinical Trials Market Share by Application (2017-2028)
6.4 North America Pediatric Clinical Trials Market Size by Country
6.4.1 North America Pediatric Clinical Trials Market Size by Country (2017-2022)
6.4.2 North America Pediatric Clinical Trials Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pediatric Clinical Trials Market Size (2017-2028)
7.2 Europe Pediatric Clinical Trials Market Size by Type
7.2.1 Europe Pediatric Clinical Trials Market Size by Type (2017-2022)
7.2.2 Europe Pediatric Clinical Trials Market Size by Type (2023-2028)
7.2.3 Europe Pediatric Clinical Trials Market Share by Type (2017-2028)
7.3 Europe Pediatric Clinical Trials Market Size by Application
7.3.1 Europe Pediatric Clinical Trials Market Size by Application (2017-2022)
7.3.2 Europe Pediatric Clinical Trials Market Size by Application (2023-2028)
7.3.3 Europe Pediatric Clinical Trials Market Share by Application (2017-2028)
7.4 Europe Pediatric Clinical Trials Market Size by Country
7.4.1 Europe Pediatric Clinical Trials Market Size by Country (2017-2022)
7.4.2 Europe Pediatric Clinical Trials Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Clinical Trials Market Size (2017-2028)
8.2 Asia-Pacific Pediatric Clinical Trials Market Size by Type
8.2.1 Asia-Pacific Pediatric Clinical Trials Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pediatric Clinical Trials Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pediatric Clinical Trials Market Share by Type (2017-2028)
8.3 Asia-Pacific Pediatric Clinical Trials Market Size by Application
8.3.1 Asia-Pacific Pediatric Clinical Trials Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pediatric Clinical Trials Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pediatric Clinical Trials Market Share by Application (2017-2028)
8.4 Asia-Pacific Pediatric Clinical Trials Market Size by Region
8.4.1 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pediatric Clinical Trials Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pediatric Clinical Trials Market Size (2017-2028)
9.2 Latin America Pediatric Clinical Trials Market Size by Type
9.2.1 Latin America Pediatric Clinical Trials Market Size by Type (2017-2022)
9.2.2 Latin America Pediatric Clinical Trials Market Size by Type (2023-2028)
9.2.3 Latin America Pediatric Clinical Trials Market Share by Type (2017-2028)
9.3 Latin America Pediatric Clinical Trials Market Size by Application
9.3.1 Latin America Pediatric Clinical Trials Market Size by Application (2017-2022)
9.3.2 Latin America Pediatric Clinical Trials Market Size by Application (2023-2028)
9.3.3 Latin America Pediatric Clinical Trials Market Share by Application (2017-2028)
9.4 Latin America Pediatric Clinical Trials Market Size by Country
9.4.1 Latin America Pediatric Clinical Trials Market Size by Country (2017-2022)
9.4.2 Latin America Pediatric Clinical Trials Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Clinical Trials Market Size (2017-2028)
10.2 Middle East & Africa Pediatric Clinical Trials Market Size by Type
10.2.1 Middle East & Africa Pediatric Clinical Trials Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pediatric Clinical Trials Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pediatric Clinical Trials Market Share by Type (2017-2028)
10.3 Middle East & Africa Pediatric Clinical Trials Market Size by Application
10.3.1 Middle East & Africa Pediatric Clinical Trials Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pediatric Clinical Trials Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pediatric Clinical Trials Market Share by Application (2017-2028)
10.4 Middle East & Africa Pediatric Clinical Trials Market Size by Country
10.4.1 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pediatric Clinical Trials Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 IQVIA Holdings, Inc.
11.1.1 IQVIA Holdings, Inc. Company Details
11.1.2 IQVIA Holdings, Inc. Business Overview
11.1.3 IQVIA Holdings, Inc. Pediatric Clinical Trials Introduction
11.1.4 IQVIA Holdings, Inc. Revenue in Pediatric Clinical Trials Business (2017-2022)
11.1.5 IQVIA Holdings, Inc. Recent Developments
11.2 Parexel International
11.2.1 Parexel International Company Details
11.2.2 Parexel International Business Overview
11.2.3 Parexel International Pediatric Clinical Trials Introduction
11.2.4 Parexel International Revenue in Pediatric Clinical Trials Business (2017-2022)
11.2.5 Parexel International Recent Developments
11.3 CenterWatch
11.3.1 CenterWatch Company Details
11.3.2 CenterWatch Business Overview
11.3.3 CenterWatch Pediatric Clinical Trials Introduction
11.3.4 CenterWatch Revenue in Pediatric Clinical Trials Business (2017-2022)
11.3.5 CenterWatch Recent Developments
11.4 Syneos Health
11.4.1 Syneos Health Company Details
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health Pediatric Clinical Trials Introduction
11.4.4 Syneos Health Revenue in Pediatric Clinical Trials Business (2017-2022)
11.4.5 Syneos Health Recent Developments
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Pediatric Clinical Trials Introduction
11.5.4 Charles River Laboratories Revenue in Pediatric Clinical Trials Business (2017-2022)
11.5.5 Charles River Laboratories Recent Developments
11.6 Covance Inc.
11.6.1 Covance Inc. Company Details
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Pediatric Clinical Trials Introduction
11.6.4 Covance Inc. Revenue in Pediatric Clinical Trials Business (2017-2022)
11.6.5 Covance Inc. Recent Developments
11.7 ICON Plc.
11.7.1 ICON Plc. Company Details
11.7.2 ICON Plc. Business Overview
11.7.3 ICON Plc. Pediatric Clinical Trials Introduction
11.7.4 ICON Plc. Revenue in Pediatric Clinical Trials Business (2017-2022)
11.7.5 ICON Plc. Recent Developments
11.8 Pharmaceutical Product Development, LLC.
11.8.1 Pharmaceutical Product Development, LLC. Company Details
11.8.2 Pharmaceutical Product Development, LLC. Business Overview
11.8.3 Pharmaceutical Product Development, LLC. Pediatric Clinical Trials Introduction
11.8.4 Pharmaceutical Product Development, LLC. Revenue in Pediatric Clinical Trials Business (2017-2022)
11.8.5 Pharmaceutical Product Development, LLC. Recent Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Pediatric Clinical Trials Introduction
11.9.4 Genentech (Roche) Revenue in Pediatric Clinical Trials Business (2017-2022)
11.9.5 Genentech (Roche) Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Pediatric Clinical Trials Introduction
11.10.4 Pfizer Revenue in Pediatric Clinical Trials Business (2017-2022)
11.10.5 Pfizer Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Pediatric Clinical Trials Introduction
11.11.4 Bristol-Myers Squibb Revenue in Pediatric Clinical Trials Business (2017-2022)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Pediatric Clinical Trials Introduction
11.12.4 GlaxoSmithKline Revenue in Pediatric Clinical Trials Business (2017-2022)
11.12.5 GlaxoSmithKline Recent Developments
11.13 Sanofi S.A.
11.13.1 Sanofi S.A. Company Details
11.13.2 Sanofi S.A. Business Overview
11.13.3 Sanofi S.A. Pediatric Clinical Trials Introduction
11.13.4 Sanofi S.A. Revenue in Pediatric Clinical Trials Business (2017-2022)
11.13.5 Sanofi S.A. Recent Developments
11.14 Novartis AG
11.14.1 Novartis AG Company Details
11.14.2 Novartis AG Business Overview
11.14.3 Novartis AG Pediatric Clinical Trials Introduction
11.14.4 Novartis AG Revenue in Pediatric Clinical Trials Business (2017-2022)
11.14.5 Novartis AG Recent Developments
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Pediatric Clinical Trials Introduction
11.15.4 Johnson & Johnson Revenue in Pediatric Clinical Trials Business (2017-2022)
11.15.5 Johnson & Johnson Recent Developments
11.16 Shire (Takeda)
11.16.1 Shire (Takeda) Company Details
11.16.2 Shire (Takeda) Business Overview
11.16.3 Shire (Takeda) Pediatric Clinical Trials Introduction
11.16.4 Shire (Takeda) Revenue in Pediatric Clinical Trials Business (2017-2022)
11.16.5 Shire (Takeda) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer